MetLife (MET)

NYSE Financials Life & Health Insurance S&P 500
$98.27
-1.48 (-1.48%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 04)
$2.85 vs $2.71 est.
Surprise +5.2%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 04, 2026Sep/2026$2.71$2.85+5.2%

Our record of MET's reports since we began tracking; it grows each quarter.

Latest results, in brief

All MET 8-K briefs →
Nov 4, 4:22 PM ET

MetLife Reports Third Quarter 2026 Results with Net Income of $2.4 Billion

Positive earnings 2.027.018.01

MetLife reported its third-quarter 2026 financial results, highlighted by net income of $2.4 billion, or $3.67 per share, driven by net derivative gains and higher adjusted earnings. Adjusted earnings increased 12% to $1.8 billion, supported by higher variable investment income, broad-based volume growth, and favorable underwriting. The company returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter.

  • Net income increased 187% to $2.4 billion, or $3.67 per share, for the third quarter of 2026.
  • Adjusted earnings rose 12% to $1.8 billion, or $2.78 per share.
  • Premiums, fees and other revenues increased 12% to $14.1 billion.
  • Total assets under management for MetLife Investment Management reached $723.4 billion.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$728.00M+17.2% $3.67+200.8% $2.40B329.3%
Jun 2026$724.00M+19.9% $1.09+5.8% $736.00M101.7%
Mar 2026$734.00M+20.1% $1.74+35.9% $1.19B161.4%
Dec 2025$600.00M+7.9% $1.17-33.9% $809.00M134.8%
Sep 2025$621.00M+12.1% $1.22-32.6% $896.00M144.3%
Jun 2025$604.00M+8.2% $1.03-19.5% $729.00M120.7%
Mar 2025$611.00M+5.9% $1.28+16.4% $945.00M154.7%
Dec 2024$556.00M-1.9% $1.77+129.9% $1.27B228.6%

From MetLife's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$2.44B+8.5% $4.71-20.7%138.7%
FY2024$2.25B+0.7% $5.94+228.2%197.1%
FY2023$2.23B+5.6% $1.81-71.3%70.8%
FY2022$2.11B+1.7% $6.30-17.6%250.4%
FY2021$2.07B+53.2% $7.65+34.7%330.5%

Frequently asked questions

When is MetLife's next earnings date?

MetLife has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did MetLife earn last quarter?

For the quarter ended Sep 2026, MetLife reported diluted EPS of $3.67 (+200.8% year over year) on revenue of $728.00M (+17.2%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.